Remove Clinical Pharmacology Remove Pharmaceuticals Remove Protein Expression Remove Protein Production
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Adams, on a first-in-human study of ELU001, a targeted c’dot drug conjugate, in subjects with folate receptor α (frα) overexpressing solid tumours, and Groothuis on the non-clinical pharmacology of the MET-targeting ADC BYON3521. Chairperson Mark Chiu, on: ‘Strategies to enhance efficacy of a tetraspecific antibody to TNBC and PDAC’.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Dimitris Skokos, PhD, Senior Director, Cancer Immunology, Regeneron Pharmaceuticals, on: ‘Tumour-targeted costimulation via CD28 bispecific antibodies: Turning immunotherapy “cold” tumours “hot”’. Alice Rothnie, DPhil, Senior Lecturer, Biochemistry, Aston University, on: ‘Membrane protein production using insect cells’.